EI
RVMD icon

Ethic Inc’s Revolution Medicines RVMD Stock Holding History

Ethic Inc’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$504K Buy
+2,690
New +$393K 0.01% 938

Other funds holding RVMD

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Ethic Inc's RVMD Position: Q2 2026 in Review

Ethic Inc opened a new position in Revolution Medicines (RVMD) in Q2 2026: 2,690 shares worth $504K. The stake represents 0.01% of the portfolio and ranks #938 among its holdings.

176 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Ethic Inc held 2,690 shares of Revolution Medicines worth $504K as of Q2 2026.
  • Revolution Medicines was a new Ethic Inc position in Q2 2026.
  • Revolution Medicines made up 0.01% of Ethic Inc's portfolio in Q2 2026, its #938 holding.
  • 176 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.